Clinical and regulatory intelligence for Meniere's Disease with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Assets: 1

Relevant assets

SPI-1005 →

Relevant companies

Sound Pharmaceuticals →

Recent signals(1)

ClinicalJuly 1, 2026

SPI-1005 Trial for Meniere's Disease Evaluates Safety and Efficacy

A clinical trial is underway to assess the safety and efficacy of SPI-1005 in treating Meniere's disease symptoms.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Meniere's Disease →

Otolaryngology →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.